Your browser doesn't support javascript.
loading
Does reproductive stage impact cardiovascular disease risk factors? Results from a population-based cohort in Lausanne (CoLaus study).
Raguindin, Peter Francis; Cardona, Isabel; Muka, Taulant; Lambrinoudaki, Irene; Gebhard, Catherine; Franco, Oscar H; Marques-Vidal, Pedro; Glisic, Marija.
Afiliação
  • Raguindin PF; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Cardona I; Swiss Paraplegic Research, Nottwil, Switzerland.
  • Muka T; Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
  • Lambrinoudaki I; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Gebhard C; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Franco OH; 2nd Department of Obstetrics and Gynecology, Medical School, Aretaieio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Marques-Vidal P; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Glisic M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Clin Endocrinol (Oxf) ; 97(5): 568-580, 2022 11.
Article em En | MEDLINE | ID: mdl-35377481
ABSTRACT
CONTEXT Menopause has been associated with adverse cardiovascular disease (CVD) risk profile, yet it is unclear whether the changes in CVD risk factors differ by reproductive stage independently of underlying ageing trajectories.

DESIGN:

The CoLaus study is a prospective population-based cohort study in Lausanne, Switzerland. PATIENTS We used data from women at baseline and follow-up (mean 5.6 ± 0.5 years) from 2003 to 2012 who did not use hormone therapy. We classified women into (i) premenopausal, (ii) menopausal transition, (iii) early (≤5 years) and (iv) late (>5 years) postmenopausal by comparing their menstruation status at baseline and follow-up. MEASUREMENTS We measured fasting lipids, glucose and cardiovascular inflammatory markers. We used repeated measures (linear mixed models) for longitudinal analysis, using premenopausal women as a reference category. We adjusted analyses for age, medications and lifestyle factors.

RESULTS:

We used the data from 1710 women aged 35-75 years. Longitudinal analysis showed that the changes in CVD risk factors were not different in the other three menopausal categories compared to premenopausal women. When age was used as a predictor variable and adjusted for menopause status, most CVD risk factors increased, while interleukin-6 and interleukin-1ß decreased with advancing age.

CONCLUSION:

The current study suggests that women have a worsening cardiovascular risk profile as they age, and although menopausal women may have higher levels of cardiovascular risk factors compared to premenopausal women at any given time, the 5-year changes in cardiovascular risk factors may not depend on the reproductive stage.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article